These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 39287840)

  • 1. Pneumatic tube transport-induced pseudohyperkalemia in patients with extreme leukocytosis: a retrospective study from a single medical center.
    Tseng YC; Lin PB; Hsieh S; Huang KL; Hsiao CT; Hsiao YC; Liu YJ; Huang YH; Wu CH
    Int J Hematol; 2024 Nov; 120(5):587-593. PubMed ID: 39287840
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pneumatic tube system transport and false hyperkalemia related to leukocytosis: a retrospective analysis.
    Grzych G; Roland E; Lezier D; Beauvais D; Maboudou P; Lippi G
    Ann Biol Clin (Paris); 2019 Jun; 77(3):281-286. PubMed ID: 31115339
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pseudohyperkalemia due to pneumatic tube transport in a leukemic patient.
    Kellerman PS; Thornbery JM
    Am J Kidney Dis; 2005 Oct; 46(4):746-8. PubMed ID: 16183430
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Early recognition of reverse pseudohyperkalemia in heparin plasma samples during leukemic hyperleukocytosis can prevent iatrogenic hypokalemia.
    Garwicz D; Karlman M
    Clin Biochem; 2012 Dec; 45(18):1700-2. PubMed ID: 22877885
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pseudohyperkalemia and extreme leukocytosis.
    Bellevue R; Dosik H; Spergel G; Gussoff BD
    J Lab Clin Med; 1975 Apr; 85(4):660-4. PubMed ID: 1120932
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Incidence, risk factors, and recognition of pseudohyperkalemia in patients with chronic lymphocytic leukemia.
    Bnaya A; Ruchlemer R; Itzkowitz E; Gabbay E; Mosenkis A; Shavit L
    Int J Hematol; 2021 Jul; 114(1):102-108. PubMed ID: 33782816
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Establishing evidence-based thresholds and laboratory practices to reduce inappropriate treatment of pseudohyperkalemia.
    Ranjitkar P; Greene DN; Baird GS; Hoofnagle AN; Mathias PC
    Clin Biochem; 2017 Aug; 50(12):663-669. PubMed ID: 28288853
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pseudohyperkalemia in chronic lymphocytic leukemia: Prevalence, impact, and management challenges.
    Bnaya A; Ganzel C; Shavit L
    Am J Med Sci; 2023 Sep; 366(3):167-175. PubMed ID: 37285937
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Reverse pseudohyperkalemia is more than leukocytosis: a retrospective study.
    El Shamy O; Rein JL; Kattamanchi S; Uribarri J; Vassalotti JA
    Clin Kidney J; 2021 May; 14(5):1443-1449. PubMed ID: 34221372
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pseudohyperkalemia in a patient with chronic lymphoblastic leukemia and tumor lysis syndrome.
    Kintzel PE; Scott WL
    J Oncol Pharm Pract; 2012 Dec; 18(4):432-5. PubMed ID: 22190579
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pseudohyperkalemia in chronic lymphocytic leukemia: phlebotomy sites and pneumatic tubes.
    Sindhu SK; Hix JK; Fricke W
    Am J Kidney Dis; 2011 Feb; 57(2):354-5. PubMed ID: 21251549
    [No Abstract]   [Full Text] [Related]  

  • 12. Pseudohyperkalemia: A new twist on an old phenomenon.
    Meng QH; Wagar EA
    Crit Rev Clin Lab Sci; 2015; 52(2):45-55. PubMed ID: 25319088
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pseudohyperkalaemia associated with leukaemic cell lysis during pneumatic tube transport of blood samples.
    Dickinson H; Webb NJ; Chaloner C; Wynn RF; Bonney DK
    Pediatr Nephrol; 2012 Jun; 27(6):1029-31. PubMed ID: 22366875
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pseudohyperkalemia in extreme leukocytosis.
    Colussi G; Cipriani D
    Am J Nephrol; 1995; 15(5):450-2. PubMed ID: 7503149
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Manual flagging failed to identify pseudohyperkalemia in acute myeloid leukemia: case report.
    Cao Y
    Int J Emerg Med; 2024 Oct; 17(1):149. PubMed ID: 39385088
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Pseudohyperkalemia: clinical chemistry for the clinician].
    Gritter M; Ramakers C; de Man RA; Hoorn EJ; Rotmans JI
    Ned Tijdschr Geneeskd; 2022 Jun; 166():. PubMed ID: 35736384
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pseudohyperkalemia in pediatric patients with newly diagnosed hematological malignancies.
    Li TC; Chan WC; Tsai MC; Tsai SF; Jan SL; Fu LS; Huang FL; Huang YC
    Pediatr Hematol Oncol; 2024 Oct; 41(7):470-479. PubMed ID: 38867542
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Impact of Undetected In Vitro Hemolysis or Sample Contamination on Patient Care and Outcomes in Point-of-Care Testing: A Retrospective Study.
    O'Hara M; Wheatley EG; Kazmierczak SC
    J Appl Lab Med; 2020 Mar; 5(2):332-341. PubMed ID: 32445387
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pseudohyperkalemia - Potassium released from cells due to clotting and centrifugation - a case report.
    Šálek T
    Biochem Med (Zagreb); 2018 Feb; 28(1):011002. PubMed ID: 29472808
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pseudohyperkalemia occurring in a patient with chronic renal failure and polycythemia vera without severe leukocytosis or thrombocytosis.
    Fukasawa H; Furuya R; Kato A; Yonemura K; Fujigaki Y; Yamamoto T; Hishida A
    Clin Nephrol; 2002 Dec; 58(6):451-4. PubMed ID: 12508968
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.